PharVision Advisers’s Mercado Libre MELI Stock Holding History

PharVision Advisers’s Portfolio MELI Stock Details MELI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-157	Closed	-$306K	–	371
2025 Q1	$306K	Buy	+157	New	+$312K	0.42%	90

Other funds holding MELI

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

PharVision Advisers's MELI Position: Q2 2025 in Review

PharVision Advisers sold out of Mercado Libre (MELI) in Q2 2025, closing a stake of 157 shares — an estimated $306K sold.

PharVision Advisers first reported a position in MELI in Q1 2025 and held it in 1 quarter. The position peaked at $306K in Q1 2025. 1,523 funds tracked by Wall St. Rank hold MELI as of Q2 2025.

PharVision Advisers reported no remaining Mercado Libre position as of Q2 2025 after selling out during the quarter.
PharVision Advisers sold 157 Mercado Libre shares in Q2 2025, an estimated $306K.
PharVision Advisers first reported a position in Mercado Libre in Q1 2025 and held it in 1 quarter.
PharVision Advisers's Mercado Libre position peaked at $306K in Q1 2025.
1,523 funds tracked by Wall St. Rank held Mercado Libre as of Q2 2025.

Based on PharVision Advisers's 13F filing for Q2 2025, filed 13 Aug 2025.